Jones Financial Companies
PDSB icon

Jones Financial Companies’s PDS Biotechnology PDSB Stock Holding History

Jones Financial Companies’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78K Hold
2,000
– – ﹤0.01% 4459
2026
Q1 		$1.08K Hold
2,000
– – ﹤0.01% 4331
2025
Q4 		$1.54K Hold
2,000
– – ﹤0.01% 3902
2025
Q3 		$2.04K Buy
+2,000
New +$2.35K ﹤0.01% 3687

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Jones Financial Companies's PDSB Position: Q2 2026 in Review

Jones Financial Companies held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 2,000 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #4459.

Jones Financial Companies first reported a position in PDSB in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.04K in Q3 2025. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Jones Financial Companies held 2,000 shares of PDS Biotechnology worth $1.78K as of Q2 2026.
  • Jones Financial Companies left its PDS Biotechnology share count unchanged in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4459 holding.
  • Jones Financial Companies first reported a position in PDS Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's PDS Biotechnology position peaked at $2.04K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.